These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 30683767)
21. The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord. Tscherpel C; Dunkl V; Ceccon G; Stoffels G; Judov N; Rapp M; Meyer PT; Kops ER; Ermert J; Fink GR; Shah NJ; Langen KJ; Galldiks N Neuro Oncol; 2017 May; 19(5):710-718. PubMed ID: 28039366 [TBL] [Abstract][Full Text] [Related]
22. Comparison of O-(2- Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ World Neurosurg; 2018 May; 113():e727-e737. PubMed ID: 29510293 [TBL] [Abstract][Full Text] [Related]
23. O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma. Hutterer M; Nowosielski M; Putzer D; Waitz D; Tinkhauser G; Kostron H; Muigg A; Virgolini IJ; Staffen W; Trinka E; Gotwald T; Jacobs AH; Stockhammer G J Nucl Med; 2011 Jun; 52(6):856-64. PubMed ID: 21622893 [TBL] [Abstract][Full Text] [Related]
24. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors. Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [ Henriksen OM; Hansen AE; Muhic A; Marner L; Madsen K; Møller S; Hasselbalch B; Lundemann MJ; Scheie D; Skjøth-Rasmussen J; Poulsen HS; Larsen VA; Larsson HBW; Law I Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4677-4691. PubMed ID: 35907033 [TBL] [Abstract][Full Text] [Related]
27. The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma. Galldiks N; Stoffels G; Filss C; Rapp M; Blau T; Tscherpel C; Ceccon G; Dunkl V; Weinzierl M; Stoffel M; Sabel M; Fink GR; Shah NJ; Langen KJ Neuro Oncol; 2015 Sep; 17(9):1293-300. PubMed ID: 26008606 [TBL] [Abstract][Full Text] [Related]
28. Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis. Dunet V; Rossier C; Buck A; Stupp R; Prior JO J Nucl Med; 2012 Feb; 53(2):207-14. PubMed ID: 22302961 [TBL] [Abstract][Full Text] [Related]
30. Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma. Munck Af Rosenschold P; Costa J; Engelholm SA; Lundemann MJ; Law I; Ohlhues L; Engelholm S Neuro Oncol; 2015 May; 17(5):757-63. PubMed ID: 25537018 [TBL] [Abstract][Full Text] [Related]
31. F18-FET PET in pediatric brain tumors: integrative analysis of image derived parameters and clinico-pathological data. Elahmadawy MA; El-Ayadi M; Ahmed S; Refaat A; Eltaoudy MH; Maher E; Taha H; Elbeltagy M Q J Nucl Med Mol Imaging; 2023 Mar; 67(1):46-56. PubMed ID: 33300749 [TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Rachinger W; Goetz C; Pöpperl G; Gildehaus FJ; Kreth FW; Holtmannspötter M; Herms J; Koch W; Tatsch K; Tonn JC Neurosurgery; 2005 Sep; 57(3):505-11; discussion 505-11. PubMed ID: 16145529 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of 18F-fluoroethyl-L-tyrosine PET and MRI in small nonspecific incidental brain lesions. Floeth FW; Sabel M; Stoffels G; Pauleit D; Hamacher K; Steiger HJ; Langen KJ J Nucl Med; 2008 May; 49(5):730-7. PubMed ID: 18413396 [TBL] [Abstract][Full Text] [Related]
34. Comparison of Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386 [TBL] [Abstract][Full Text] [Related]
37. O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy. Sweeney R; Polat B; Samnick S; Reiners C; Flentje M; Verburg FA Ann Nucl Med; 2014 Feb; 28(2):154-62. PubMed ID: 24272067 [TBL] [Abstract][Full Text] [Related]